Log In Sign up
The largest database of trusted experimental protocols

Clone epr3912

Manufactured by Abcam
Visit Supplier

Clone EPR3912 is a recombinant rabbit monoclonal antibody that recognizes an epitope within the amino-terminal region of the human PIM1 protein. It is suitable for use in various applications, including immunohistochemistry, immunocytochemistry, and Western blotting.

Automatically generated - may contain errors

Lab products found in correlation

Clone 8g7g3 1, by Agilent Technologies (2 mentions) Clone l50 823, by Cell Marque (2 mentions) Clone 304 1a5, by Agilent Technologies (2 mentions) Clone 36b5, by Leica (2 mentions) Clone bc28, by Biocare Medical (2 mentions) Clone ve1, by Abcam (2 mentions)

2 protocols using clone epr3912

1

Immunohistochemistry Markers for Characterizing Unusual Cases

Check if the same lab product or an alternative is used in the 5 most similar protocols
We recently described the immunohistochemistry (IHC) setup at MGH (27 ). IHC markers that were employed in this study as needed to characterize morphologically unusual and genetically altered cases included TTF1 (performed in cases 1, 52, 53; clone 8G7G3/1; dilution 1:300; Dako, Carpinteria, CA), BRG1 (performed in case 9; clone EPR3912; dilution 1:50; Abcam, Cambridge, United Kingdom), GATA3 (performed in case 25; clone L50–823, dilution 1:200; Cell Marque, Rocklin, CA), mammaglobin (performed in case 25; clone 304–1A5; dilution 1:250; Dako, Carpinteria, CA), S100 protein (performed in case 25; polyclonal and prediluted; Ventana, Oro Valley, AZ), PAX8 (performed in cases 25, 52, 53; polyclonal, dilution 1:1000; Proteintech, Rosemont, IL), thyroglobulin (performed in cases 25, 52; dilution 1:800; Cell Marque, Rocklin, CA), E-cadherin (performed in case 46; clone 36B5; Leica Biosystems, Buffalo Grove, IL), p40 (performed in case 52; clone BC28, Biocare, Concord, MA) and BRAF V600E (performed in all cases; clone VE1; dilution 1:200; Abcam, Cambridge, United Kingdom).
Chu Y.H., Wirth L.J., Farahani A.A., Nosé V., Faquin W.C., Dias-Santagata D, & Sadow P.M. (2020). Clinicopathologic Features of Kinase Fusion-related Thyroid Carcinomas: An Integrative Analysis with Molecular Characterization. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 33(12), 2458-2472.
+ Open protocol
+ Expand
2

Immunohistochemistry Markers for Characterizing Unusual Cases

Check if the same lab product or an alternative is used in the 5 most similar protocols
We recently described the immunohistochemistry (IHC) setup at MGH (27 ). IHC markers that were employed in this study as needed to characterize morphologically unusual and genetically altered cases included TTF1 (performed in cases 1, 52, 53; clone 8G7G3/1; dilution 1:300; Dako, Carpinteria, CA), BRG1 (performed in case 9; clone EPR3912; dilution 1:50; Abcam, Cambridge, United Kingdom), GATA3 (performed in case 25; clone L50–823, dilution 1:200; Cell Marque, Rocklin, CA), mammaglobin (performed in case 25; clone 304–1A5; dilution 1:250; Dako, Carpinteria, CA), S100 protein (performed in case 25; polyclonal and prediluted; Ventana, Oro Valley, AZ), PAX8 (performed in cases 25, 52, 53; polyclonal, dilution 1:1000; Proteintech, Rosemont, IL), thyroglobulin (performed in cases 25, 52; dilution 1:800; Cell Marque, Rocklin, CA), E-cadherin (performed in case 46; clone 36B5; Leica Biosystems, Buffalo Grove, IL), p40 (performed in case 52; clone BC28, Biocare, Concord, MA) and BRAF V600E (performed in all cases; clone VE1; dilution 1:200; Abcam, Cambridge, United Kingdom).
Chu Y.H., Wirth L.J., Farahani A.A., Nosé V., Faquin W.C., Dias-Santagata D, & Sadow P.M. (2020). Clinicopathologic Features of Kinase Fusion-related Thyroid Carcinomas: An Integrative Analysis with Molecular Characterization. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 33(12), 2458-2472.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!